No Data
ETF Market Wrap | A-shares Drop on Lower Volume, S&P Consumer ETF Rises 2.53%
Gelonghui December 2nd | The three major A-share indices collectively fell today. At the close, the Shanghai Composite Index dropped 0.42% to 3897 points, the Shenzhen Component Index fell 0.68%, and the ChiNext Index declined 0.69%. The total market turnover reached RMB 1.61 trillion, decreasing by RMB 282.2 billion compared to the previous trading day, with over 3700 stocks falling. The lithium battery industry chain led the declines, while innovative drugs, GPUs, robotics, photovoltaics, AI applications, semiconductors, and new energy vehicle concept stocks also experienced significant losses. In contrast, cross-strait integration, pharmaceutical commerce, and consumer electronics sectors showed resilience. Regarding ETFs, robust Black Friday consumption data in the U.S. drove the Invesco Great Wall Fund S&P Consumer Discretionary ETF up by 2%.
ETF funds have accelerated net purchases of Hong Kong stock assets in the second half of the year, with strong inflows into the CSI HK-H Shares Internet ETF, Hong Kong Securities ETF, and CSI HK-H Shares Non-Banking Financials ETF.
Southbound capital has been highly active, with cumulative net purchases of Hong Kong stocks reaching HKD 1.38 trillion so far this year, the highest on record. Driven by southbound capital, the valuation of Hong Kong stock assets has improved, with the Hang Seng Index gaining nearly 30% year-to-date and the Hang Seng Tech Index rising over 25% in the same period. ETF fund flows corroborate the positive buying sentiment toward Hong Kong stocks. Following market volatility in the second half of the year, ETF funds have adopted a 'buy-the-dip' strategy, accelerating net purchases of Hong Kong stock assets. Since the second half of the year, the net inflow of funds into the CSI Southern China Internet ETF has exceeded RMB 35 billion, while the net inflows for the Hong Kong Securities ETF and the CSI Southern China Non-Banking ETF have surpassed RMB 20 billion.
The Latest Movement of the Largest Influx of Capital!
Tycoon Refutes AI Bubble Theory
ETF Market Review | The decline in the photovoltaic sector narrowed in the afternoon, with both the CSI New Energy ETF and the CSI Photovoltaic ETF Index Fund falling by 4%.
Gelonghui, November 12 | A-share market fluctuated throughout the day, with the Shanghai Composite Index closing down 0.07% and the ChiNext Index falling 0.39%. The photovoltaic industry chain and nuclear fusion concept led declines, while cultivated diamonds and super-hard materials saw significant pullbacks. The insurance, pharmaceutical, and banking sectors performed strongly, with Agricultural Bank of China and ICBC both hitting new highs; ABC's market capitalization exceeded RMB 3 trillion. In the ETF sector, innovative drug stocks rebounded across the board, with Harvest Fund’s S&P Biotech ETF, YinHua Fund’s Hong Kong Stock Connect Innovative Drug ETF, and HuiTianFu Fund’s Hong Kong Stock Connect Innovative Drug ETF rising 3.61%, 3.14%, and 3.1%, respectively. The Hong Kong stock dividend sector continued its recent upward trend.
Midday ETF Review | Broad-based Rebound in the Innovative Drug Sector, S&P Biotech ETF Up 3.8%
Gelonghui, November 12 | The three major A-share indices collectively fell today. As of the close, the Shanghai Composite Index dropped by 0.24%, the Shenzhen Component Index declined by 1.07%, and the ChiNext Index fell by 1.58%. The total trading volume of the Shanghai, Shenzhen, and Beijing markets reached RMB 1.2702 trillion, an increase of RMB 22 billion compared to the previous day. More than 4,000 stocks in the entire market ended lower. In terms of sector performance, oil and gas extraction and services, insurance, brain-computer interface, banking, and influenza-related sectors led gains. In contrast, photovoltaic equipment, lab-grown diamonds, controlled nuclear fusion, phosphorus chemical industry, batteries, military equipment, and lithography machine-related stocks were among the top decliners. Regarding ETFs, the innovative drug sector rebounded across the board, with the S&P Biotech index showing notable improvement.
Afternoon Market Rebound! Has the Reason Been Identified?
Did 'The Big Short' overturn global stock markets?